Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas

<div>Validation of the 12 selected target genes using the GEPIA server. EIF6, DDX18, MRTO4, NOP2, PES1, RPF2, RPL4, WDR36, BOP1, DDX47, and DDX56 all positively correlated with GTPBP4 in LUAD, whereas DDX5 was negatively correlated with GTPBP4.</div>

BioMed Research International

fig7

Figure 7

Figure 7: Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas 

Figure 7 | Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas 